Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Breast
Study Phase
Phase 3
Study Completion Date
January 2016
NCT00382070Uploaded 08-11-2021
Access via NCI by Request
PDS UID: nci-data-476
A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
Files: NCT00382070-D1
Data DictionaryNCT00382070-D1-Data-Dictionary_1.pdf
DATANCT00382070-D1-Dataset.txt
OTHERREADME.pdf
Files: NCT00382070-D2
Data DictionaryNCT00382070-D2-Data-Dictionary_1.pdf
DATANCT00382070-D2-Dataset.txt
OTHERREADME.pdf